Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学Cytokines in Cancer, Clinical Trials

Elad Sharon

MD, MPH

🏢National Cancer Institute🌐USA

Senior Investigator, Cancer Therapy Evaluation Program

52
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Elad Sharon leads immunotherapy trial strategy within NCI Cancer Therapy Evaluation Program (CTEP) and has coordinated federal portfolios of cytokine and checkpoint inhibitor combinations. He helps design and prioritize NCI-sponsored trials exploring cytokines and immune modulators. His work shapes national immunotherapy trial agendas.

Share:

🧪Research Fields 研究领域

NCI CTEP immunotherapy trials
cytokine combinations
checkpoint inhibitors
biomarker studies
immune related adverse events

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-04-01 | All information from publicly available academic sources

关注 Elad Sharon 的研究动态

Follow Elad Sharon's research updates

留下邮箱,当我们发布与 Elad Sharon(National Cancer Institute)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment